Axillary Recurrence After a Tumor-Positive Sentinel Lymph Node Biopsy Without Axillary Treatment: A Review of the Literature

BACKGROUND: Sentinel lymph node biopsy (SLNB) has become standard of care as a staging procedure in patients with invasive breast cancer. A positive SLNB allows completion axillary lymph node dissection (cALND) to be performed. The axillary recurrence rate (ARR) after cALND in patients with positive...

Descripción completa

Detalles Bibliográficos
Autores principales: Francissen, Claire M. T. P., Dings, Pim J. M., van Dalen, Thijs, Strobbe, Luc J. A., van Laarhoven, Hanneke W. M., de Wilt, Johannes H. W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505491/
https://www.ncbi.nlm.nih.gov/pubmed/22890590
http://dx.doi.org/10.1245/s10434-012-2490-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505491/
https://www.ncbi.nlm.nih.gov/pubmed/22890590
http://dx.doi.org/10.1245/s10434-012-2490-4

Ejemplares similares